Company Data
Rallybio Corporation
Ticker
RLYB
Current Price
$8.22 -1.32%
Market Cap
$43.5M
Price Target
Refer to Report
Volume
32.6K
52wk Range
$1.9 - $11.49
Overview
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.